Changing Paradigms in the Management of VTE in Patients With Cancer

WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.

Faculty

Menno V. Huisman, MD

Professor and Internist
Cardiovascular Medicine
Department of Thrombosis and Hemostasis
Leiden University Medical Center (LUMC)
Leiden, Netherlands

Disclosures

Disclosure: Menno V. Huisman, MD, has the following relevant financial relationships:
Advisor or consultant for: Bayer Healthcare; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo; Pfizer
Speaker or a member of a speakers bureau for: Bayer Healthcare; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo; Pfizer
Grants for clinical research from: Bayer Healthcare; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo; Pfizer

Cihan Ay, MD

Professor at Department of Medicine I, Clinical Division of Haematology and Haemostaseology
Medical University of Vienna,
Vienna, Austria

Disclosures

Disclosure: Cihan Ay, MD, has the following relevant financial relationships:
Advisor or consultant for: Bayer; Sanofi
Speaker or a member of a speakers bureau for: Bayer; Bristol Myers Squibb; Daiichi-Sankyo; Pfizer; Sanofi

Editor

Ozerk Akgun, MD

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Ozerk Akgun, MD, has disclosed no relevant financial relationships.

Content Reviewer

Susan L. Smith, MN, PhD

Associate Director, Accreditation and Compliance

Disclosures

Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.